Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer
Our findings suggest that CHMP4C might be a prognostic biomarker in PCa, potentially offering novel perspectives for the advancement of precision therapy for PCa.
Authors
- Jun Mi (ORCID: https://orcid.org/0000-0002-9205-4107)
- Xi Xiao (ORCID: https://orcid.org/0000-0003-1495-4561)
- Liangliang Qing
- Xiaoyu Di (ORCID: https://orcid.org/0009-0002-4966-0635)
- Fuxiang Ye (ORCID: https://orcid.org/0000-0003-2550-2173)
- Zonglin Li (ORCID: https://orcid.org/0000-0002-1729-9593)
- Qingchao Li (ORCID: https://orcid.org/0000-0002-0307-0085)
- Yanan Wang (ORCID: https://orcid.org/0009-0007-2744-7733)
- Yajia Dong
Institutions
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- BMC Medical Genomics
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1186/s12920-024-01970-z
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.84